Price
No data yet.
Social Signal Score
Revenue
$8.30B+107.55%Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $15.43B | $3.00B | $0.39 |
| 2024 | $14.80B | $2.64B | $0.34 |
| 2023 | $13.17B | $2.19B | $0.28 |
| 2022 | $10.49B | $2.25B | $0.41 |
| 2021 | $10.27B | $1.78B | $0.33 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from CSLLY's reported EPS growth of 4.3% a year over 4 years.
- EPS in 5 years
- $0.96
- Implied price
- $17.22
- Return from $23.95
- -6.4% a year
To earn 15.0% a year on these assumptions you'd need to buy at $8.56 — -64.2% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| -5.7% | -21.9% | -18.4% | -15.4% | -12.7% | -10.3% |
| -0.7% | -17.8% | -14.1% | -10.9% | -8.1% | -5.6% |
| 4.3% | -13.7% | -9.7% | -6.4% | -3.4% | -0.8% |
| 9.3% | -9.5% | -5.4% | -1.9% | 1.2% | 3.9% |
| 14.3% | -5.4% | -1.1% | 2.6% | 5.8% | 8.7% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
100Social Signal Score
Mentions (1)
- Newsreuters.com·7h ago·Neutral
Australia's CSL reports 2% fall in annual profit Australia's CSL on Tuesday posted a 2% fall in annual profit, dragged by declining revenue at its core plasma division.
View source ↗
Earnings
Mon, Aug 17(date passed)
Estimates and results for CSLLY via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.